ET
SRPT icon

Entropy Technologies’s Sarepta Therapeutics SRPT Stock Holding History

Entropy Technologies’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$535K Buy
29,749
+10,075
+51% +$191K 0.02% 651
2026
Q1 		$428K Sell
19,674
-16,007
-45% -$310K 0.02% 618
2025
Q4 		$768K Sell
35,681
-10,449
-23% -$220K 0.04% 451
2025
Q3 		$889K Buy
+46,130
New +$822K 0.07% 353
2025
Q2 		– Sell
-22,501
Closed -$1.44M – 1004
2025
Q1 		$1.44M Buy
+22,501
New +$2.37M 0.14% 203
2024
Q3 		– Sell
-6,037
Closed -$954K – 926
2024
Q2 		$954K Buy
+6,037
New +$776K 0.1% 249

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Entropy Technologies's SRPT Position: Q2 2026 in Review

Entropy Technologies increased its Sarepta Therapeutics (SRPT) stake by 51% in Q2 2026, buying an estimated $191K and bringing the position to 29,749 shares worth $535K. The position accounts for 0.02% of the portfolio, ranked #651.

Entropy Technologies first reported a position in SRPT in Q2 2024 and has held it in 6 quarters since. The position peaked at $1.44M in Q1 2025. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Entropy Technologies held 29,749 shares of Sarepta Therapeutics worth $535K as of Q2 2026.
  • Entropy Technologies bought 10,075 Sarepta Therapeutics shares in Q2 2026, an estimated $191K.
  • Sarepta Therapeutics made up 0.02% of Entropy Technologies's portfolio in Q2 2026, its #651 holding.
  • Entropy Technologies first reported a position in Sarepta Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • Entropy Technologies's Sarepta Therapeutics position peaked at $1.44M in Q1 2025.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.